Aspirin can have ‘huge effect’ in stopping colorectal cancer returning, study finds
PositiveWorld Affairs

A recent study by Swedish researchers reveals that a low daily dose of aspirin can significantly lower the risk of colorectal cancer returning in post-surgery patients with specific gene mutations. This finding is crucial as it offers a simple and accessible way to enhance recovery and improve long-term outcomes for patients who have undergone tumor removal. By potentially halving the recurrence rate over three years, this research highlights the importance of aspirin as a preventive measure in cancer care.
— Curated by the World Pulse Now AI Editorial System